4/A: Orchestra BioMed Holdings Director Corrects Transaction Codes in Form 4 Amendment

David P. Hochman, a director at Orchestra BioMed Holdings, filed an amendment to a previous Form 4 to correct transaction codes related to recent stock purchases.

Summary

• David P. Hochman, a director at Orchestra BioMed Holdings, filed an amended Form 4 with the SEC on May 21, 2024.
• The amendment corrects transaction codes in Table I of the original Form 4 filed on May 20, 2024.
• The corrected transaction code is 'P', indicating a purchase of common stock.
• On May 16, 2024, Hochman purchased 2,000 shares of common stock at a weighted average price of $4.75, with prices ranging from $4.74 to $4.78.
• On May 17, 2024, Hochman purchased 3,000 shares of common stock at a weighted average price of $5.15, with prices ranging from $4.92 to $5.36.
• Following these transactions, the DPH 2008 Trust beneficially owns 332,502 shares of Orchestra BioMed Holdings common stock.

Sentiment

Score: 5

Explanation: This is a routine correction of a regulatory filing, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Key Dates